Analysis of Influencing Factors and Construction of Prediction Models of Artificial Joint Replacement in China

December 30, 2021 updated by: Xiangya Hospital of Central South University
The project intends to analyze the epidemiological characteristics, risk factors, complications and resource utilization of artificial joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The HQMS database is a mandatory electronic inpatient database system developed by the National Health Commission of the People's Republic of China. Since 2013, tertiary hospitals have been required to upload their inpatient discharge records. By 2019, the HQMS database has included more than 230 million standardized inpatient discharge records of over 1000 hospitals across all 31 provincial-level administrative regions in mainland China. Patient demographics, clinical diagnosis, procedures and operations, drug use, costs and complications were all recorded in the HQMS database. The investigators planned to include five types of arthroplasty, including knee arthroplasty, hip arthroplasty, shoulder arthroplasty, ankle arthroplasty and elbow arthroplasty. The data analysis will be conformed to the principle of confidentiality and will not reveal the privacy of those patients. The data will be only used for this research project and there is no conflict of interest. It is in line with the principles of ethics, harmlessness and fairness. This study was authorized by the HQMS Committee Board and approved by the institutional review board, with waiver of informed consent.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

600000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hunan
      • Changsha, Hunan, China, 410008
        • Xiangya Hospital of Central South University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who underwent knee, hip, shoulder, ankle and elbow arthroplasty were included.

Description

Inclusion Criteria:

  • Patients who underwent knee, hip, shoulder, ankle and elbow arthroplasty in HQMS

Exclusion Criteria:

  • Patients who didn't undergo knee, hip, shoulder, ankle and elbow arthroplasty
  • Patients with missing demographics or medical data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
patients undergoing knee arthroplasty in Hospital Quality Monitoring System in China
Patients who underwent knee arthroplasty and was recorded in HQMS were included in this group
patients undergoing hip arthroplasty in Hospital Quality Monitoring System in China
Patients who underwent hip arthroplasty and was recorded in HQMS were included in this group
patients undergoing shoulder arthroplasty in Hospital Quality Monitoring System in China
Patients who underwent shoulder arthroplasty and was recorded in HQMS were included in this group
patients undergoing ankle arthroplasty in Hospital Quality Monitoring System in China
Patients who underwent ankle arthroplasty and was recorded in HQMS were included in this group
patients undergoing elbow arthroplasty in Hospital Quality Monitoring System in China
Patients who underwent elbow arthroplasty and was recorded in HQMS were included in this group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Epidemiological characteristics, complications, risk factors and resource utilization of knee arthroplasty in China
Time Frame: 10 years (2013-2022)
The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial knee joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.
10 years (2013-2022)
Epidemiological characteristics, complications, risk factors and resource utilization of hip arthroplasty in China
Time Frame: 10 years (2013-2022)
The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial hip joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.
10 years (2013-2022)
Epidemiological characteristics, complications, risk factors and resource utilization of shoulder arthroplasty in China
Time Frame: 10 years (2013-2022)
The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial shoulder joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.
10 years (2013-2022)
Epidemiological characteristics, complications, risk factors and resource utilization of ankle arthroplasty in China
Time Frame: 10 years (2013-2022)
The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial ankle joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.
10 years (2013-2022)
Epidemiological characteristics, complications, risk factors and resource utilization of elbow arthroplasty in China
Time Frame: 10 years (2013-2022)
The project intends to analyze the epidemiological characteristics, complications, risk factors and resource utilization of artificial elbow joint replacement in China through the inpatient data collected by the Hospital Quality Monitoring System (HQMS). The information collected by HQMS includes demographics characteristics, hospitalization information, medical care cost, complications, et al.
10 years (2013-2022)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guanghua Lei, PhD; MD, Xiangya Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Anticipated)

December 1, 2022

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

December 8, 2021

First Submitted That Met QC Criteria

December 8, 2021

First Posted (Actual)

December 27, 2021

Study Record Updates

Last Update Posted (Actual)

January 14, 2022

Last Update Submitted That Met QC Criteria

December 30, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017121016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The investigators do not wish to share our data according to the policy of our hospital, the data could not be shared with others without permission.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthropathy

3
Subscribe